Biohaven (BHVN) Gains from Investment Securities (2021 - 2026)

Biohaven has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $837000.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $837000.0, down 70.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$158000.0 (down 101.17% YoY), and the FY2025 annual result was $1.8 million, down 84.2% from the prior year.
• Gains from Investment Securities came in at $837000.0 for Q1 2026 at Biohaven, up from -$3.6 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $38.2 million in Q4 2022 to a low of -$4.7 million in Q4 2023.
• The 5-year median for Gains from Investment Securities is $1.3 million (2025), against an average of $3.3 million.
• Across the five-year window, Gains from Investment Securities surged 874.4% in 2023 and tumbled 171.88% in 2025, its largest moves.
• Biohaven's Gains from Investment Securities stood at $38.2 million in 2022, then slumped by 112.3% to -$4.7 million in 2023, then surged by 205.47% to $5.0 million in 2024, then tumbled by 171.88% to -$3.6 million in 2025, then surged by 123.51% to $837000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $837000.0 (Q1 2026), -$3.6 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.